IGFBP2 and glioblastoma: IGFBP2 is considered as one of the strongest biomarkers of aggressive behavior in GBM (Holmes, 2012; Phillips et al., 2016) and also a prognostic marker for survival (McDonald et al., 2007; Phillips et al., 2016).